The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva

先天免疫对进行性骨化性纤维发育不良异位骨化的贡献

基本信息

  • 批准号:
    10249238
  • 负责人:
  • 金额:
    $ 42.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Fibrodysplasia ossificans progressiva (FOP) is a rare, currently untreatable, congenital disease in which skeletal muscle repair is redirected to endochondral bone formation (heterotopic ossification, HO) causing pain, muscle destruction, and joint fusion, leading to progressive immobilization and eventually premature death. FOP is caused by a mutation in Alk2 (most commonly R206H) that renders the receptor sensitive to aberrant activation by Activin A (ActA). However, the “flares” that lead to HO appear to be initiated by inflammatory insults, and HO can be reduced in FOP mice by depletion of inflammatory innate immune cells including macrophages. Fibroadipoprogenitors (FAPs), residing in the muscle interstitium appear to be the critical precursors of chondrocytes in FOP. However, in healthy muscle repair, macrophages secrete TNFα at a critical time to trigger apoptosis of FAPs. The fact that FAPs survive and differentiate into chondrocytes suggests their interaction with macrophages is disrupted in FOP. Therefore, this proposal will explore the hypothesis that pro-inflammatory M1-like and anti-inflammatory M2-like macrophages are critical sources of cytokines that enable survival and expansion of the chondrogenic fibroadipoprogenitors in FOP. Specifically, it seeks to determine whether macrophages are a critical source of ActA and what signals pathways in FAPS are disrupted to block their normal apoptotic fate. These studies will be the first to explore the mechanisms by which macrophages interact with chondrogenic FAPs to support chondrogenesis and HO, and they will provide critical insights to the early stages of FOP flares.
进行性骨化性纤维发育不良(FOP)是一种罕见的、目前无法治疗的先天性疾病, 骨骼肌修复重定向至软骨内骨形成(异位骨化,HO), 疼痛,肌肉破坏和关节融合,导致进行性固定,最终过早 死亡FOP是由Alk2(最常见的是R206 H)突变引起的,该突变使受体对 激活素A(Activin A,ActA)。然而,导致HO的“耀斑”似乎是由 在FOP小鼠中,HO可以通过消耗炎性先天免疫细胞来减少 包括巨噬细胞。纤维脂肪祖细胞(FAP),居住在肌肉软骨似乎是 FOP中软骨细胞的关键前体。然而,在健康的肌肉修复中,巨噬细胞分泌TNFα, FAPs凋亡的临界时间。FAP存活并分化为软骨细胞的事实 表明它们与巨噬细胞的相互作用在FOP中被破坏。因此,本提案将探讨 假设促炎性M1样和抗炎性M2样巨噬细胞是 能够使FOP中软骨形成纤维脂肪祖细胞存活和扩增的细胞因子。具体地说, 它试图确定巨噬细胞是否是ActA的关键来源以及FAPS中的信号通路 被破坏以阻止其正常的凋亡命运。这些研究将是第一个探索机制, 巨噬细胞与软骨形成FAP相互作用,以支持软骨形成和HO,它们将提供 对FOP耀斑早期阶段的重要见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel S Perrien其他文献

Daniel S Perrien的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel S Perrien', 18)}}的其他基金

The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
  • 批准号:
    10434101
  • 财政年份:
    2019
  • 资助金额:
    $ 42.39万
  • 项目类别:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
  • 批准号:
    10150273
  • 财政年份:
    2019
  • 资助金额:
    $ 42.39万
  • 项目类别:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
  • 批准号:
    10168215
  • 财政年份:
    2019
  • 资助金额:
    $ 42.39万
  • 项目类别:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
  • 批准号:
    10407678
  • 财政年份:
    2019
  • 资助金额:
    $ 42.39万
  • 项目类别:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
先天免疫对进行性骨化性纤维发育不良异位骨化的贡献
  • 批准号:
    10616939
  • 财政年份:
    2019
  • 资助金额:
    $ 42.39万
  • 项目类别:
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
免疫细胞和细胞因子介导进行性骨化性纤维发育不良
  • 批准号:
    8871583
  • 财政年份:
    2015
  • 资助金额:
    $ 42.39万
  • 项目类别:
vivaCT80 - in vivo small animal microCT
vivaCT80 - 小动物体内显微 CT
  • 批准号:
    8639867
  • 财政年份:
    2014
  • 资助金额:
    $ 42.39万
  • 项目类别:
Interventions and Mechanisms of Disuse Osteopenia
废用性骨质减少的干预措施和机制
  • 批准号:
    8774183
  • 财政年份:
    2013
  • 资助金额:
    $ 42.39万
  • 项目类别:
Interventions and Mechanisms of Disuse Osteopenia
废用性骨质减少的干预措施和机制
  • 批准号:
    8667309
  • 财政年份:
    2013
  • 资助金额:
    $ 42.39万
  • 项目类别:
Interventions and Mechanisms of Disuse Osteopenia
废用性骨质减少的干预措施和机制
  • 批准号:
    8442139
  • 财政年份:
    2013
  • 资助金额:
    $ 42.39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了